Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TMEM106B: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TMEM106B is a gene implicated in neurodegeneration research. Key relationships include: associated with, therapeutic target, interacts with. Associated with Aging, Als, Alzheimer. Connected to 27 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TMEM106B |
| Aliases | Transmembrane Protein 106B |
| Chromosome | 7p21.3 |
| Protein Family | Type II lysosomal transmembrane protein family |
| Function | is a 323-amino acid type II lysosomal transmembrane protein encoded by the TMEM106B gene on chromosome 7p21. |
| Primary Expression | Late endosomes and lysosomes |
| Molecular Weight | 30.3 kDa |
| Amino Acids | 274 aa |
| Exons | 9 |
| Pathways | Autophagy, endosome-lysosome function |
| UniProt ID | Q9NUM4 |
| GeneCards | TMEM106B |
| Human Protein Atlas | TMEM106B |
| Molecular weight | Approximately 31 kDa |
| Topology | Type II transmembrane protein (N-out, C-in) |
| Associated Diseases | Aging, Als, Alzheimer, Alzheimer's disease |
| Interactions | Actin, ALZHEIMER, ALZHEIMER DISEASE, AMYLOID, AND, APOE |
| KG Connections | 383 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TMEM106B["TMEM106B"]
endosome_lysosome_function(["endosome-lysosome function"])
TMEM106B -->|"regulates"| endosome_lysosome_function
Alzheimer{"Alzheimer"}
TMEM106B -->|"associated with"| Alzheimer
TMEM106B -->|"therapeutic target"| Alzheimer
Ms{"Ms"}
TMEM106B -->|"therapeutic target"| Ms
Dementia{"Dementia"}
TMEM106B -->|"therapeutic target"| Dementia
Als{"Als"}
TMEM106B -->|"therapeutic target"| Als
TMEM106B -->|"associated with"| Als
Aging{"Aging"}
TMEM106B -->|"associated with"| Aging
TMEM106B -->|"interacts with"| Dementia
SIGLEC9["SIGLEC9"]
TMEM106B -->|"associated with"| SIGLEC9
SIRPA["SIRPA"]
TMEM106B -->|"associated with"| SIRPA
GRN["GRN"]
TMEM106B -->|"associated with"| GRN
ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
ALZHEIMER_S_DISEASE -->|"associated with"| TMEM106B
TREM2["TREM2"]
TREM2 -->|"associated with"| TMEM106B
ALZHEIMER_S_DISEASE -->|"therapeutic target"| TMEM106B
CTSH["CTSH"]
CTSH -->|"associated with"| TMEM106B
FTLD["FTLD"]
FTLD -->|"associated with"| TMEM106B
MAPT["MAPT"]
MAPT -->|"associated with"| TMEM106B
style TMEM106B fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:TMEM106B | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| Cell Subtype Proportion | regulates | phenotype | 0.90 |
| oxidative stress response | participates_in | pathway | 0.80 |
| endosome-lysosome function | regulates | pathway | 0.70 |
| lipid metabolism | participates_in | pathway | 0.70 |
| TDP-43 pathology | regulates | process | 0.70 |
| lysosomal function | modulates | process | 0.70 |
| neurodegeneration | associated_with | process | 0.70 |
| Neurodegeneration | regulates | disease | 0.65 |
| Cerebral Amyloid Angiopathy | expressed_in | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | regulates | disease | 0.65 |
| Dementia | regulates | disease | 0.65 |
| Parkinson | regulates | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Aging | causes | disease | 0.65 |
| Ms | biomarker_for | disease | 0.65 |
| Ftd | associated_with | disease | 0.65 |
| Frontotemporal Dementia | biomarker_for | disease | 0.65 |
| Dementia | biomarker_for | disease | 0.65 |
| Als | biomarker_for | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Schizophrenia | biomarker_for | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | biomarker_for | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Ms | causes | disease | 0.65 |
| Frontotemporal Dementia | causes | disease | 0.65 |
| AUTOPHAGY | associated_with | phenotype | 0.65 |
| Neurodegeneration | causes | disease | 0.65 |
| Dementia | causes | disease | 0.65 |
| Als | causes | disease | 0.65 |
| Alzheimer | causes | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | causes | disease | 0.65 |
| Ftd | causes | disease | 0.65 |
| FRONTOTEMPORAL DEMENTIA | increases_risk | disease | 0.65 |
| DEMENTIA | increases_risk | disease | 0.65 |
| FRONTOTEMPORAL DEMENTIA | regulates | disease | 0.65 |
| LYSOSOMAL DYSFUNCTION | inhibits | phenotype | 0.65 |
| FRONTOTEMPORAL DEMENTIA | treats | disease | 0.65 |
| OLIGODENDROCYTE | degrades | cell_type | 0.65 |
| DEMYELINATION | activates | phenotype | 0.65 |
| AUTOPHAGY | inhibits | phenotype | 0.65 |
| AUTOPHAGY | treats | phenotype | 0.65 |
| AGING | increases_risk | phenotype | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:TMEM106B | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| ALZHEIMER DISEASE | associated_with | gene | 0.80 |
| DEMENTIA | inhibits | disease | 0.65 |
| C9orf72 | interacts_with | gene | 0.65 |
| GAUCHER DISEASE | activates | disease | 0.65 |
| PTK2B | inhibits | gene | 0.60 |
| FTLD | associated_with | gene | 0.60 |
| ALS | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | regulates | gene | 0.60 |
| NEURODEGENERATION | regulates | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | regulates | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | causes | gene | 0.60 |
| AUTOPHAGY | causes | gene | 0.60 |
| AMYLOID | expressed_in | gene | 0.60 |
| ALZHEIMER | expressed_in | gene | 0.60 |
| RNA | expressed_in | gene | 0.60 |
| MICROGLIA | expressed_in | gene | 0.60 |
| PARKINSON | expressed_in | gene | 0.60 |
| SIGLEC9 | associated_with | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| GRN | inhibits | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
| DNA | interacts_with | gene | 0.60 |
| ALS | co_expressed_with | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| TAR | interacts_with | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | causes | gene | 0.60 |
| AND | causes | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | biomarker_for | gene | 0.60 |
| APOE | interacts_with | gene | 0.60 |
| GRN | protects_against | gene | 0.60 |
| GRN | biomarker_for | gene | 0.60 |
| GRN | interacts_with | gene | 0.60 |
| SORL1 | interacts_with | gene | 0.60 |
| CHMP2B | causes | gene | 0.60 |
| ANXA11 | causes | gene | 0.60 |
| CCNF | causes | gene | 0.60 |
| CHCHD10 | causes | gene | 0.60 |
| CHCHD2 | causes | gene | 0.60 |
| CYLD | causes | gene | 0.60 |
| FUS | causes | gene | 0.60 |
| GRN | causes | gene | 0.60 |
| MAPT | causes | gene | 0.60 |
| OPTN | causes | gene | 0.60 |
| PRNP | causes | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism and Therapeu | validation | Neurodegeneration | 0.400 | 0.50 | human | proposed | $2,730,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning TMEM106B in their description or question text
No additional research found